SJ Medical
SJ Medical
The global market for vascular intervention is shifting toward minimally invasive procedures that offer reduced recovery times and improved clinical outcomes. China, spearheaded by pioneers like Hangzhou SJ Medical Co., Ltd., has emerged as a dominant force. This white paper explores the technical nuances, manufacturing rigor, and global trade dynamics that define the current EVLT landscape.
Established in 2015, Hangzhou SJ Medical Co., Ltd. is dedicated to the research, development, and commercialization of vascular interventional medical devices. Our focus spans both cardiovascular and peripheral intervention fields.
SJ Medical has developed a comprehensive product portfolio covering balloon catheters for coronary and peripheral applications, supporting access devices, and advanced stent systems.
Through continuous innovation, the company has obtained multiple patents and international certifications (CE, ISO 13485, CFDA), laying a solid foundation for sustainable growth.
The core of EVLT lies in the precise delivery of thermal energy to the vein wall. Our technical roadmap focuses on three pillars of innovation:
Moving from the standard 980nm to 1470nm wavelengths. The 1470nm laser is absorbed specifically by water in the vein wall, resulting in less bruising and faster recovery compared to earlier hemoglobin-targeted lasers.
Developing 360-degree radial emitting fibers that ensure uniform energy distribution, significantly reducing the risk of vein perforation and post-operative pain.
Integrating real-time feedback loops that adjust laser power based on vessel diameter and blood flow velocity detected via integrated ultrasound sensors.
SJ Medical operates a modern manufacturing facility with a total area of approximately 5,000 square meters. Our production environment is the bedrock of our reliability:
As of 2024, the demand for EVLT systems in Europe and Southeast Asia has grown by 18% annually. SJ Medical addresses this through localized support and strategic exports.
We have established long-term partnerships in Italy, Spain, France, India, Indonesia, Turkey, and Egypt. Our logistics chain is optimized for the cold-chain requirements of specific medical components.
We offer OEM/ODM services for hospital groups and private labels, providing full technical documentation to assist in local regulatory filings.
Adhering to ISO 13485 and obtaining CE certification allows our partners to integrate our devices into their national healthcare systems with zero friction.
Navigating the global medical market requires more than just a good product; it requires a deep understanding of regional compliance. SJ Medical provides:
Comprehensive clinical trial data and performance reports to satisfy EU MDR and other stringent regulatory frameworks.
IFUs (Instructions for Use) and technical manuals available in multiple languages to support local clinical staff.
A responsive technical support system that provides 24/7 assistance to our global distributors, ensuring procedural continuity.
A: China offers a unique combination of high-precision manufacturing at scale, rapid R&D cycles, and cost-efficiency. Factories like SJ Medical utilize the same high-grade materials and cleanroom standards as Western manufacturers but benefit from a more integrated supply chain.
A: Every batch undergoes rigorous testing, including burst pressure tests, trackability assessments, and biocompatibility screening. Our ISO 13485 certification ensures every step of production is documented and traceable.
A: Yes. We have a dedicated technical team that works with healthcare providers to develop custom balloon sizes, stent lengths, and laser fiber configurations tailored to specific surgical requirements.
A: Depending on the order volume and customization, lead times range from 4 to 8 weeks. We utilize major logistics hubs in Shanghai and Ningbo for efficient global shipping.
